Accuracy of Point of Care (POC) or In-office Urine Drug Testing (Immunoassay) in Chronic Pain Patients

Accuracy of Point of Care (POC) or In-office Urine Drug Testing (Immunoassay) in Chronic Pain Patients: A Prospective Analysis of Immunoassay and Liquid Chromatography Tandem Mass Spectometry (LC/MS/MS)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01052155

Enrollment

1000

Registered

2010-01-20

Start date

2010-02-28

Completion date

2010-06-30

Last updated

2011-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain

Keywords

Controlled substances, Opioids, Benzodiazepines, Illicit drugs, Immunoassay drug testing, Point of care (POC) testing, Liquid Chromatography Tandem Mass Spectometry

Brief summary

Detailed description

Recruitment is indicated in patients with chronic pain management with or without controlled substance therapy. This is a diagnostic accuracy study performed in an interventional pain management referral center in the United States.

Interventions

OTHERUrine Drug Testing

LC/MS/MS Laboratory Evaluation

Study design

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

• Chronic pain management with or without controlled substance therapy.

Exclusion criteria

None

Design outcomes

Primary

Measure	Time frame
Diagnostic accuracy	72 hours

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 29, 2026